Strain identifier

BacDive ID: 1695

Type strain: Yes

Species: Bifidobacterium breve

Strain Designation: S1

Strain history: CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain S1

NCBI tax ID(s): 518634 (strain), 1685 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 9.3 (current version):
version 9.2:
version 9.1:
version 9:
version 8.1:
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 9.3 (current version)

General

@ref: 8482

BacDive-ID: 1695

DSM-Number: 20213

keywords: genome sequence, 16S sequence, Bacteria, anaerobe, mesophilic, Gram-positive, rod-shaped

description: Bifidobacterium breve S1 is an anaerobe, mesophilic, Gram-positive bacterium that was isolated from intestine of infant.

NCBI tax id

NCBI tax idMatching level
1685species
518634strain

strain history

@refhistory
8482<- G. Reuter, S1
67770ATCC 15700 <-- G. Reuter S1 (Variant a).
117003CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain S1

doi: 10.13145/bacdive1695.20250331.9.3

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Bifidobacteriales
  • family: Bifidobacteriaceae
  • genus: Bifidobacterium
  • species: Bifidobacterium breve
  • full scientific name: Bifidobacterium breve Reuter 1963 (Approved Lists 1980)

@ref: 8482

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Bifidobacteriales

family: Bifidobacteriaceae

genus: Bifidobacterium

species: Bifidobacterium breve

full scientific name: Bifidobacterium breve Reuter 1963 emend. Nouioui et al. 2018

strain designation: S1

type strain: yes

Morphology

cell morphology

@refgram staincell shapemotilityconfidence
117003positiverod-shapedno
125438no91

colony morphology

  • @ref: 117003

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
8482BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58)yeshttps://mediadive.dsmz.de/medium/58Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water
42088MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
117003CIP Medium 20yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20

culture temp

@refgrowthtypetemperature
8482positivegrowth37
42088positivegrowth37
67770positivegrowth37

Physiology and metabolism

oxygen tolerance

  • @ref: 8482
  • oxygen tolerance: anaerobe

spore formation

  • @ref: 125439
  • spore formation: no
  • confidence: 90.9

murein

  • @ref: 8482
  • murein short key: A11.01
  • type: A3alpha L-Lys-Gly

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
1170034853esculin+hydrolysis
11700317632nitrate-reduction
11700316301nitrite-reduction
68371Potassium 5-ketogluconate-builds acid from
68371320061methyl alpha-D-glucopyranoside+builds acid from
6837117634D-glucose+builds acid from
6837112936D-galactose+builds acid from
6837116988D-ribose+builds acid from
6837130849L-arabinose-builds acid from
6837117113erythritol-builds acid from
6837117754glycerol-builds acid from
68371Potassium 2-ketogluconate-builds acid from
6837124265gluconate-builds acid from
6837118403L-arabitol-builds acid from
6837118333D-arabitol-builds acid from
6837128847D-fucose-builds acid from
6837116443D-tagatose-builds acid from
6837162318D-lyxose-builds acid from
6837132528turanose+builds acid from
6837128087glycogen+builds acid from
6837116634raffinose+builds acid from
683716731melezitose-builds acid from
6837115443inulin-builds acid from
6837127082trehalose-builds acid from
6837117992sucrose+builds acid from
6837128053melibiose+builds acid from
6837117716lactose+builds acid from
6837117306maltose+builds acid from
6837117057cellobiose+builds acid from
6837117814salicin+builds acid from
683714853esculin+builds acid from
6837159640N-acetylglucosamine+builds acid from
6837143943methyl alpha-D-mannoside-builds acid from
6837117924D-sorbitol+builds acid from
6837116899D-mannitol+builds acid from
6837117268myo-inositol-builds acid from
6837116813galactitol-builds acid from
6837162345L-rhamnose-builds acid from
6837117266L-sorbose-builds acid from
6837115824D-fructose+builds acid from
6837174863methyl beta-D-xylopyranoside-builds acid from
6837115963ribitol-builds acid from
6837165328L-xylose-builds acid from
6837165327D-xylose-builds acid from

antibiotic resistance

  • @ref: 117003
  • ChEBI: 6909
  • metabolite: metronidazole
  • is antibiotic: yes
  • is sensitive: no
  • is resistant: yes

metabolite production

  • @ref: 117003
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

enzymes

@refvalueactivityec
68382alpha-fucosidase-3.2.1.51
68382alpha-mannosidase-3.2.1.24
68382N-acetyl-beta-glucosaminidase+3.2.1.52
68382alpha-glucosidase+3.2.1.20
68382beta-glucosidase+3.2.1.21
68382beta-galactosidase+3.2.1.23
68382beta-glucuronidase-3.2.1.31
68382alpha-galactosidase+3.2.1.22
68382naphthol-AS-BI-phosphohydrolase-
68382acid phosphatase+3.1.3.2
68382alpha-chymotrypsin-3.4.21.1
68382cystine arylamidase-3.4.11.3
68382trypsin-3.4.21.4
68382valine arylamidase-
68382lipase (C 14)-
68382leucine arylamidase+3.4.11.1
68382esterase lipase (C 8)-
68382esterase (C 4)+
68382alkaline phosphatase-3.1.3.1
117003oxidase-
117003beta-galactosidase+3.2.1.23
117003gelatinase-
117003amylase-
117003DNase-
117003caseinase+3.4.21.50
117003catalase-1.11.1.6
117003tween esterase-
117003lecithinase-
117003lipase-
117003protease-
117003urease-3.5.1.5

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
117003--+--+----+-++-+++--

API 50CHac

@refQGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
8482---+-+----++++----++-+++++++++++---+-+--+---+-----
8482-----+----+++-----++-+++++++++++---+-+--+---+-----
8482---+-+----++++----++-+++++++++++---++/-++/-++---+-----
8482---+-+----++++----++-+++++++++++---++++/-++---+-----
8482---+-+----++++----++-+++++++++++---++++++---+-----
8482-----+----++++/-----++-++--+++++++---+-+--+---+/------

Isolation, sampling and environmental information

isolation

@refsample type
8482intestine of infant
67770Intestine of infant
117003Human, Infant, intestine

isolation source categories

Cat1Cat2Cat3
#Host#Human#Child
#Host Body-Site#Gastrointestinal tract

taxonmaps

  • @ref: 69479
  • File name: preview.99_711.png
  • url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_24;96_219;97_238;98_571;99_711&stattab=map
  • Last taxonomy: Bifidobacterium breve subclade
  • 16S sequence: LC071793
  • Sequence Identity:
  • Total samples: 147666
  • soil counts: 1133
  • aquatic counts: 3177
  • animal counts: 142996
  • plant counts: 360

Safety information

risk assessment

@refpathogenicity humanbiosafety levelbiosafety level comment
8482yes, in single cases1Risk group (German classification)
1170031Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: ATCC 15700AB0066581520nuccore518634
20218Bifidobacterium breve partial 16S rRNA gene, type strain ATCC 15700TAM411121179nuccore518634
20218Bifidobacterium breve 16S ribosomal RNAM587311536nuccore1685
20218Bifodibacterium breve (ATCC 15700) 16S ribosomal RNA gene, partialM84776642nuccore1685
20218Bifidobacterium breve strain DSM 20213 16S ribosomal RNA gene, partial sequenceHQ012023939nuccore518634
20218Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: JCM 1192AB116288479nuccore518634
20218Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: JCM 1192AB507084672nuccore518634
20218Bifidobacterium breve strain KCTC 3220 16S ribosomal RNA gene, partial sequenceGU3618151483nuccore1685
67770Bifidobacterium breve gene for 16S ribosomal RNA, partial sequence, strain: JCM 1192LC0717931418nuccore518634

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Bifidobacterium breve NCTC11815GCA_900637145completencbi1685
66792Bifidobacterium breve DSM 20213 = JCM 1192GCA_001025175completencbi518634
66792Bifidobacterium breve DSM 20213 = JCM 1192518634.7wgspatric518634
66792Bifidobacterium breve DSM 20213 = JCM 1192518634.21wgspatric518634
66792Bifidobacterium breve DSM 20213 = JCM 1192518634.20completepatric518634
66792Bifidobacterium breve DSM 20213 = JCM 1192518634.19wgspatric518634
66792Bifidobacterium breve strain NCTC118151685.200completepatric1685
66792Bifidobacterium breve DSM 20213, JCM 1192643886102draftimg518634
66792Bifidobacterium breve DSM 20213, JCM 11922728369679draftimg518634
66792Bifidobacterium breve DSM 202132667527587draftimg518634
66792Bifidobacterium breve DSM 202132859463870completeimg518634
67770Bifidobacterium breve DSM 20213 = JCM 1192GCA_000158015scaffoldncbi518634
67770Bifidobacterium breve DSM 20213 = JCM 1192 DNA, complete genomeAP012324ncbi518634
67770Bifidobacterium breve DSM 20213 = JCM 1192GCA_001311295contigncbi518634
67770Bifidobacterium breve DSM 20213 = JCM 1192GCA_000771305contigncbi518634

GC content

@refGC-contentmethod
848258.4
6777058.4thermal denaturation, midpoint method (Tm)

Genome-based predictions

predictions

@refmodeltraitdescriptionpredictionconfidencetraining_data
125438gram-positivegram-positivePositive reaction to Gram-stainingyes86.506no
125438anaerobicanaerobicAbility to grow under anoxygenic conditions (including facultative anaerobes)yes84.179yes
125438aerobicaerobicAbility to grow under oxygenic conditions (including facultative aerobes)no91.783yes
125438spore-formingspore-formingAbility to form endo- or exosporesno89.505no
125438thermophilethermophilicAbility to grow at temperatures above or equal to 45°Cno93.467yes
125438motile2+flagellatedAbility to perform flagellated movementno91no
125439BacteriaNetspore_formationAbility to form endo- or exosporesno90.9
125439BacteriaNetmotilityAbility to perform movementno54.2
125439BacteriaNetgram_stainReaction to gram-stainingpositive75
125439BacteriaNetoxygen_toleranceOxygenic conditions needed for growthobligate aerobe75.1

External links

@ref: 8482

culture collection no.: DSM 20213, ATCC 15700, NCTC 11815, JCM 1192, BCRC 11846, CCUG 18365, CCUG 30511, CECT 4839, CGMCC 1.2213, CIP 64.69, KCTC 3220, LMG 10501, LMG 11042, NCFB 2257, NCDO 2257, WDCM 00224

straininfo link

  • @ref: 71342
  • straininfo: 92168

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity8872711Growth characteristics of bifidobacteria in infant formulas.Dubey UK, Mistry VVJ Dairy Sci10.3168/jds.S0022-0302(96)76468-81996Acetic Acid/metabolism, Animals, Bifidobacterium/cytology/*growth & development, Buffers, Caseins, Fats/analysis, Humans, Hydrogen-Ion Concentration, Infant Food/analysis/*microbiology, Infant, Newborn, Kinetics, Lactic Acid/biosynthesis, Milk, Protein Hydrolysates, Proteins/analysis, SoybeansEnzymology
Pathogenicity8872712Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas.Dubey UK, Mistry VVJ Dairy Sci10.3168/jds.S0022-0302(96)76469-X1996Acetic Acid/metabolism, Bifidobacterium/*drug effects/*growth & development, Caseins, Colony Count, Microbial, Fructose/*pharmacology, Humans, Hydrogen-Ion Concentration, Infant, Infant Food/analysis/*microbiology, Lactic Acid/biosynthesis, Lactulose/*pharmacology, Oligosaccharides/*pharmacology, Protein Hydrolysates, SoybeansMetabolism
Metabolism9003583Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria.Tahri K, Grill JP, Schneider FCurr Microbiol10.1007/s0028499001481997Animals, Bifidobacterium/growth & development/*metabolism, Bile/*metabolism, Cattle, Cholagogues and Choleretics/pharmacology, Cholesterol/analysis/*metabolism/*pharmacology, Cholic Acid, Cholic Acids/pharmacology, Kinetics, Taurocholic Acid/pharmacologyEnzymology
Cultivation10849172Effects of fructooligosaccharides and their monomeric components on bile salt resistance in three species of bifidobacteria.Perrin S, Grill JP, Schneider FJ Appl Microbiol10.1046/j.1365-2672.2000.01070.x2000Animals, Bifidobacterium/*drug effects/enzymology/growth & development, Bile Acids and Salts/*pharmacology, Cattle, Culture Media, Drug Resistance, Microbial, Fructose/pharmacology, Glucose/pharmacology, Glycodeoxycholic Acid/pharmacology, Glycoside Hydrolases/metabolism, Oligosaccharides/*pharmacology, beta-FructofuranosidaseEnzymology
Metabolism11510661The effect of nisin on the physiology of Bifidobacterium thermophilum.Kot E, Murad Y, Bezkorovainy AJ Food Prot10.4315/0362-028x-64.8.12062001Anti-Bacterial Agents/*pharmacology, Bifidobacterium/drug effects/growth & development/*physiology, Ferric Compounds/*metabolism, Lactic Acid/metabolism, Nisin/*pharmacology, Time FactorsPhysiology
Metabolism12904543Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria.Kurdi P, Tanaka H, van Veen HW, Asano K, Tomita F, Yokota AMicrobiology (Reading)10.1099/mic.0.26376-02003Acetic Acid/pharmacology, Bifidobacterium/*drug effects/*metabolism, Bile Acids and Salts/metabolism, Biological Transport, Active/drug effects, Butyric Acid/pharmacology, Cholic Acid/*metabolism, Energy Metabolism, Fatty Acids, Volatile/*metabolism/*pharmacology, Humans, Hydrogen-Ion Concentration, Kinetics, Propionates/pharmacologyPathogenicity
Metabolism15222478Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp.Kim WS, Ohashi M, Tanaka T, Kumura H, Kim GY, Kwon IK, Goh JS, Shimazaki KBiometals10.1023/b:biom.0000027705.57430.f12004Animals, Bifidobacterium/*growth & development/metabolism, Cattle, Cell Fractionation, Cell Membrane/chemistry, Lactobacillus acidophilus/*growth & development/metabolism, Lactoferrin/chemistry/*metabolism
Phylogeny16391119Modulation of rat cecal microbiota by administration of raffinose and encapsulated Bifidobacterium breve.Dinoto A, Suksomcheep A, Ishizuka S, Kimura H, Hanada S, Kamagata Y, Asano K, Tomita F, Yokota AAppl Environ Microbiol10.1128/AEM.72.1.784-792.20062006Administration, Oral, Animals, Bacteria/classification/genetics/*isolation & purification, Bifidobacterium/genetics/*growth & development/isolation & purification, Cecum/*microbiology, *Dietary Supplements, In Situ Hybridization, Fluorescence, Male, Oligonucleotide Probes, Polymorphism, Restriction Fragment Length, Raffinose/*administration & dosage, RatsEnzymology
Pathogenicity16484210Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria.Kurdi P, Kawanishi K, Mizutani K, Yokota AJ Bacteriol10.1128/JB.188.5.1979-1986.20062006Bifidobacterium/*drug effects/metabolism, Bile Acids and Salts/*pharmacology, Cell Membrane/drug effects/metabolism, Chenodeoxycholic Acid/pharmacology, Cholic Acid/pharmacology, Deoxycholic Acid/pharmacology, Hydrogen-Ion Concentration, Lactobacillus/*drug effects/metabolism, Membrane Potentials, Microbial Sensitivity TestsMetabolism
Pathogenicity17434219Yoghurt fermented by Lactobacillus delbrueckii subsp. bulgaricus H+ -ATPase-defective mutants exhibits enhanced viability of Bifidobacterium breve during storage.Ongol MP, Sawatari Y, Ebina Y, Sone T, Tanaka M, Tomita F, Yokota A, Asano KInt J Food Microbiol10.1016/j.ijfoodmicro.2007.02.0192007Bifidobacterium/*growth & development, Colony Count, Microbial, Fermentation, Food Handling/*methods, Food Preservation/*methods, Humans, Hydrogen-Ion Concentration, Lactobacillus delbrueckii/genetics/*physiology, Mutation, Proton-Translocating ATPases/*deficiency/genetics, Temperature, Time Factors, Yogurt/*microbiology
Pathogenicity17927741Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, Yamaguchi KJ Appl Microbiol10.1111/j.1365-2672.2007.03593.x2007Administration, Oral, Animals, Antibiosis, Bacterial Adhesion, *Bifidobacterium, Colony Count, Microbial, Gastroenteritis/immunology/microbiology/*therapy, Gastrointestinal Tract/microbiology, Immunocompromised Host, Male, Mice, Mice, Inbred ICR, Probiotics/*administration & dosage, Pseudomonas Infections/immunology/microbiology/*therapy, *Pseudomonas aeruginosa/growth & development, Sepsis/immunology/microbiology/*therapy
Pathogenicity18837471Synbiotic promotion of epithelial proliferation by orally ingested encapsulated Bifidobacterium breve and raffinose in the small intestine of rats.Ishizuka S, Iwama A, Dinoto A, Suksomcheep A, Maeta K, Kasai T, Hara H, Yokota AMol Nutr Food Res10.1002/mnfr.2008000412009Animals, Bifidobacterium/*physiology, Bromodeoxyuridine/analysis, Cecum/chemistry/cytology/microbiology, Cell Division/*drug effects, Colon/cytology, Epithelial Cells/*cytology, Hydrogen-Ion Concentration, Intestine, Small/*cytology, Male, Probiotics/*administration & dosage, Raffinose/*administration & dosage, Rats
Metabolism19694435In vitro fermentation of arabinoxylan-derived carbohydrates by bifidobacteria and mixed fecal microbiota.Pastell H, Westermann P, Meyer AS, Tuomainen P, Tenkanen MJ Agric Food Chem10.1021/jf901397b2009Arabinose/metabolism, Bifidobacterium/genetics/growth & development/*metabolism, DNA, Bacterial/analysis, Feces/*microbiology, *Fermentation, Humans, Hydrogen-Ion Concentration, Oligosaccharides/*metabolism, Species Specificity, Xylans/*metabolism, Xylose/metabolismPathogenicity
Pathogenicity20583474The influence of some probiotic supernatants on the growth and virulence features expression of several selected enteroaggregative E. coli clinical strains.Lazar V, Miyazaki Y, Hanawa T, Chifiriuc MC, Ditu LM, Marutescu L, Bleotu C, Kamiya SRoum Arch Microbiol Immunol2009Bacterial Adhesion, Bifidobacterium/growth & development, Cell Line, Colony Count, Microbial, Culture Media, Conditioned/chemistry/*pharmacology, Diarrhea/microbiology, Enterococcus faecium/growth & development, Epithelial Cells/microbiology, Escherichia coli/drug effects/*growth & development/*pathogenicity, Escherichia coli Infections/microbiology, Humans, Lactobacillus casei/growth & development, *Probiotics, VirulenceCultivation
Metabolism21832085Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka MJ Biol Chem10.1074/jbc.M111.2481382011Adult, Bifidobacteriales Infections/microbiology, Bifidobacterium/*metabolism, Carbohydrates/chemistry, Chromatography, High Pressure Liquid/methods, Female, Gastrointestinal Tract/microbiology, Humans, Infant, Newborn, Intestines/*microbiology, Japan, Milk, Human/*metabolism, Molecular Sequence Data, Monosaccharides, Oligosaccharides/chemistry/*metabolism, Time FactorsPathogenicity
Metabolism22612915Characterization of a Panela cheese with added probiotics and fava bean starch.Escobar MC, Van Tassell ML, Martinez-Bustos F, Singh M, Castano-Tostado E, Amaya-Llano SL, Miller MJJ Dairy Sci10.3168/jds.2011-46552012Bifidobacterium/metabolism, *Cheese/standards, Food Microbiology/*methods, Food Technology/methods, Hydrolysis, Lactobacillus/metabolism, Probiotics/*metabolism, *Starch/metabolism, *Vicia faba/metabolismBiotechnology
Pathogenicity22897719Identification and accurate quantitation of biological oligosaccharide mixtures.Strum JS, Kim J, Wu S, De Leoz ML, Peacock K, Grimm R, German JB, Mills DA, Lebrilla CBAnal Chem10.1021/ac301128s2012Bifidobacterium/enzymology, *Chromatography, High Pressure Liquid, Deuterium Exchange Measurement, Gastrointestinal Tract/microbiology, Glycoside Hydrolases/metabolism, Humans, *Mass Spectrometry, Milk, Human/chemistry, Oligosaccharides/*analysisEnzymology
Phylogeny23315725Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin.Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao JZ, Abe F, Iwatsuki KAppl Environ Microbiol10.1128/AEM.03343-122013Animals, Bifidobacterium/*drug effects/*growth & development, Cattle, Growth Inhibitors/*isolation & purification/pharmacology, Hydrolysis, Intercellular Signaling Peptides and Proteins/*isolation & purification/pharmacology, Lactoferrin/*metabolism, Microbial Sensitivity Tests, Pepsin A/*metabolismEnzymology
Metabolism25089712Two beta-galactosidases from the human isolate Bifidobacterium breve DSM 20213: molecular cloning and expression, biochemical characterization and synthesis of galacto-oligosaccharides.Arreola SL, Intanon M, Suljic J, Kittl R, Pham NH, Kosma P, Haltrich D, Nguyen THPLoS One10.1371/journal.pone.01040562014Bacterial Proteins/genetics/*metabolism, Bifidobacterium/*enzymology/genetics/isolation & purification, Chaperonin 10/genetics/metabolism, Chaperonin 60/genetics/metabolism, Cloning, Molecular, Escherichia coli/genetics/metabolism, Galactose/metabolism, Gene Expression, Glucose/metabolism, Humans, Hydrogen-Ion Concentration, Infant, Intestines/microbiology, Isoenzymes/genetics/metabolism, Kinetics, Lactose/metabolism, Molecular Weight, Oligosaccharides/*biosynthesis, Protein Multimerization, Temperature, beta-Galactosidase/genetics/*metabolismEnzymology
25866754A Novel Lactobacillus casei LP1 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Stimulator.Kang JE, Kim TJ, Moon GSPrev Nutr Food Sci10.3746/pnf.2015.20.1.782015
Pathogenicity26083838RNA of Enterococcus faecalis Strain EC-12 Is a Major Component Inducing Interleukin-12 Production from Human Monocytic Cells.Nishibayashi R, Inoue R, Harada Y, Watanabe T, Makioka Y, Ushida KPLoS One10.1371/journal.pone.01298062015Cells, Cultured, Enterococcus faecalis/*immunology, Gram-Positive Bacterial Infections/*immunology/microbiology, Humans, Interleukin-12/*immunology, Leukocytes, Mononuclear/immunology/microbiology, Monocytes/immunology/*microbiology, RNA, Bacterial/*immunologyBiotechnology
Genetics26142063Complete genome sequence of Bifidobacterium breve JCM 1192(T) isolated from infant feces.Morita H, Toh H, Oshima K, Nakano A, Omori E, Hattori Y, Arakawa K, Suda W, Honda K, Hattori MJ Biotechnol10.1016/j.jbiotec.2015.06.4142015Base Composition, Bifidobacterium/*genetics, Feces/*microbiology, Genome Size, *Genome, Bacterial, Humans, Infant, Molecular Sequence Annotation, Molecular Sequence Data, Sequence Analysis, DNA/*methodsPathogenicity
Pathogenicity26689225Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response.Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, Leenen PJBenef Microbes10.3920/BM2015.00942015Age Factors, Aging/drug effects/*immunology, Animals, Bifidobacterium/*physiology, Humans, Interleukin-10/immunology, Interleukin-6/immunology, Lactobacillus/*physiology, Macrophages/drug effects/*immunology, Male, Mice, Mice, Inbred C57BL, Probiotics/*pharmacology, Spleen/cytology/drug effects/*immunology, Tumor Necrosis Factor-alpha/immunology
Enzymology26749248In vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus).Liu Z, Wang W, Huang G, Zhang W, Ni LJ Sci Food Agric10.1002/jsfa.76042016Animals, Cecum/microbiology, *Cooking, Enterococcus/isolation & purification, Feces/microbiology, Gastrointestinal Contents, Male, *Prebiotics, Prunus dulcis/*chemistry, Rats, Rats, Wistar, Specific Pathogen-Free OrganismsPhylogeny
27774093Supplementation with Lactobacillus plantarum WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging Ercc1(-/Delta7) Mice.van Beek AA, Sovran B, Hugenholtz F, Meijer B, Hoogerland JA, Mihailova V, van der Ploeg C, Belzer C, Boekschoten MV, Hoeijmakers JH, Vermeij WP, de Vos P, Wells JM, Leenen PJ, Nicoletti C, Hendriks RW, Savelkoul HFFront Immunol10.3389/fimmu.2016.004082016
Metabolism28115383Mechanistic Study of Utilization of Water-Insoluble Saccharomyces cerevisiae Glucans by Bifidobacterium breve Strain JCM1192.Keung HY, Li TK, Sham LT, Cheung MK, Cheung PCK, Kwan HSAppl Environ Microbiol10.1128/AEM.03442-162017ATP-Binding Cassette Transporters/genetics/metabolism, Bacterial Proteins/genetics/metabolism, Bifidobacterium breve/drug effects/genetics/growth & development/*metabolism, Cell Wall/chemistry/metabolism, Dextrins/pharmacology, Glucans/*metabolism, Glycogen/pharmacology, Glycoside Hydrolases/genetics/metabolism, Hydrolysis, Maltose/metabolism/pharmacology, Mutation, Saccharomyces cerevisiae/*chemistry, Solubility, Synbiotics, Water, beta-Glucans/metabolismPathogenicity
Metabolism28780103Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli.Thongaram T, Hoeflinger JL, Chow J, Miller MJJ Dairy Sci10.3168/jds.2017-127532017Animals, Bifidobacterium/*metabolism, Humans, Lactobacillus/*metabolism, Milk, Human/*chemistry, Oligosaccharides/*metabolism, Probiotics/metabolismPathogenicity
Phylogeny29116036Bifidobacterium callitrichidarum sp. nov. from the faeces of the emperor tamarin (Saguinus imperator).Modesto M, Michelini S, Sansosti MC, De Filippo C, Cavalieri D, Qvirist L, Andlid T, Spiezio C, Sandri C, Pascarelli S, Sgorbati B, Mattarelli PInt J Syst Evol Microbiol10.1099/ijsem.0.0024722017Aldehyde-Lyases/chemistry, Animals, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/genetics/isolation & purification, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/microbiology, Multilocus Sequence Typing, Peptidoglycan/chemistry, *Phylogeny, RNA, Ribosomal, 16S/genetics, Saguinus/*microbiology, Sequence Analysis, DNATranscriptome
Enzymology30518022Highly Selective Production of Compound K from Ginsenoside Rd by Hydrolyzing Glucose at C-3 Glycoside Using beta-Glucosidase of Bifidobacterium breve ATCC 15700.Zhang R, Huang XM, Yan HJ, Liu XY, Zhou Q, Luo ZY, Tan XN, Zhang BLJ Microbiol Biotechnol10.4014/jmb.1808.080592019Bacterial Proteins/genetics/metabolism, Bifidobacterium breve/genetics/*metabolism, Biotransformation, Cloning, Molecular, Enzyme Assays, Enzyme Stability, Escherichia coli/genetics, Gene Expression Regulation, Bacterial, Ginsenosides/biosynthesis/chemistry/*metabolism, Glucose/*metabolism, Glycosides, Hydrogen-Ion Concentration, Hydrolysis, Kinetics, Monosaccharides/*metabolism, Recombinant Proteins/genetics/isolation & purification/metabolism, Substrate Specificity, beta-Glucosidase/genetics/isolation & purification/*metabolismMetabolism
31861103Effects of Linoleic Acid on Gut-Derived Bifidobacterium breve DSM 20213: A Transcriptomic Approach.Senizza A, Callegari ML, Senizza B, Minuti A, Rocchetti G, Morelli L, Patrone VMicroorganisms10.3390/microorganisms71207102019
Metabolism32265475Linoleic acid induces metabolic stress in the intestinal microorganism Bifidobacterium breve DSM 20213.Senizza A, Rocchetti G, Callegari ML, Lucini L, Morelli LSci Rep10.1038/s41598-020-62897-w2020Bifidobacterium breve/growth & development/*metabolism, Biosynthetic Pathways, Intestines/*microbiology, Linoleic Acid/*metabolism, Linoleic Acids, Conjugated/metabolism, Metabolome, Oxidation-Reduction, Oxidative Stress, Stress, PhysiologicalStress
32545606Evaluation of Bifidobacteria and Lactobacillus Probiotics as Alternative Therapy for Salmonella typhimurium Infection in Broiler Chickens.El-Sharkawy H, Tahoun A, Rizk AM, Suzuki T, Elmonir W, Nassef E, Shukry M, Germoush MO, Farrag F, Bin-Jumah M, Mahmoud AMAnimals (Basel)10.3390/ani100610232020
Biotechnology33134584Impact of prebiotics on equol production from soymilk isoflavones by two Bifidobacterium species.Mustafa SE, Mustafa S, Ismail A, Abas F, Abd Manap MY, Ahmed Hamdi OA, Elzen S, Nahar L, Sarker SDHeliyon10.1016/j.heliyon.2020.e052982020
Pathogenicity34024895Safety Evaluation of Bifidobacterium breve IDCC4401 Isolated from Infant Feces for Use as a Commercial Probiotic.Choi IY, Kim J, Kim SH, Ban OH, Yang J, Park MKJ Microbiol Biotechnol10.4014/jmb.2103.030412021Anti-Bacterial Agents/pharmacology, Bacterial Proteins/metabolism, Bifidobacterium breve/drug effects/genetics/*isolation & purification, Drug Resistance, Bacterial, Feces/*microbiology, *Food Safety, Genes, Bacterial, Genome, Bacterial/genetics, Humans, Infant, Lactic Acid/metabolism, Microbial Sensitivity Tests, *Probiotics, Vancomycin/pharmacologyPhylogeny
Phylogeny34721319Comparison of 16S rRNA Gene Based Microbial Profiling Using Five Next-Generation Sequencers and Various Primers.Park C, Kim SB, Choi SH, Kim SFront Microbiol10.3389/fmicb.2021.7155002021

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
8482Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20213)https://www.dsmz.de/collection/catalogue/details/culture/DSM-20213
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
42088Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/10175
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
66794Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg10.1093/nar/gkaa1025BRENDA, the ELIXIR core data resource in 2021: new developments and updatesNucleic Acids Res. 49: D498-D508 202033211880
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68371Automatically annotated from API 50CH acid
68382Automatically annotated from API zym
69479João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.https://microbeatlas.org/MicrobeAtlas 1.0 beta
71342Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID92168.1StrainInfo: A central database for resolving microbial strain identifiers
117003Curators of the CIPCollection of Institut Pasteur (CIP 64.69)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2064.69
125438Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann10.1101/2024.08.12.607695Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets
125439Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardyhttps://github.com/GenomeNet/deepGdeepG: Deep Learning for Genome Sequence Data. R package version 0.3.1